|
DKC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.48020004534055E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24529999645517E-08 |
| Normal-vs-Stage2 |
2.171500E-04 |
| Normal-vs-Stage3 |
1.99180000048926E-07 |
| Normal-vs-Stage4 |
2.67709999945964E-07 |
| Stage1-vs-Stage2 |
7.412800E-01 |
| Stage1-vs-Stage3 |
7.342800E-01 |
| Stage1-vs-Stage4 |
7.316600E-01 |
| Stage2-vs-Stage3 |
6.179000E-01 |
| Stage2-vs-Stage4 |
6.284200E-01 |
| Stage3-vs-Stage4 |
9.902400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88429996237505E-09 |
| Normal-vs-AfricanAmerican |
6.423400E-04 |
| Normal-vs-Asian |
1.51304999999047E-05 |
| Caucasian-vs-AfricanAmerican |
8.191800E-01 |
| Caucasian-vs-Asian |
9.733600E-01 |
| AfricanAmerican-vs-Asian |
8.452800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.34360025514513E-10 |
| Normal-vs-Female |
4.47889999533047E-08 |
| Male-vs-Female |
8.383600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.75120000114981E-08 |
| Normal-vs-Age(41-60Yrs) |
1.83149999999355E-06 |
| Normal-vs-Age(61-80Yrs) |
1.47589995780351E-09 |
| Normal-vs-Age(81-100Yrs) |
3.016800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.271000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.657600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.404400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.900200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.419800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.431200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.935600E-01 |
| Classical-VS-Follicular |
3.694200E-02 |
| Classical-VS-Other |
5.027400E-01 |
| Classical-VS-Normal |
1.13419999947517E-07 |
| Tall-VS-Follicular |
5.525000E-01 |
| Tall-VS-Other |
7.512600E-01 |
| Tall-VS-Normal |
4.13180000000679E-05 |
| Follicular-VS-Other |
9.109800E-01 |
| Follicular-VS-Normal |
4.3793000004122E-07 |
| Other-VS-Normal |
9.964300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.89339999631966E-08 |
| Normal-vs-N1 |
1.58690000029438E-08 |
| N0-vs-N1 |
1.870250E-01 |
|
|
